Abstract: Provided herein are MAPT RNAi agents and compositions comprising a MAPT RNAi agent. Also provided herein are methods of using the MAPT RNAi agents or compositions comprising a MAPT RNAi agent for reducing MAPT expression and/or treating tauopathy in a subject.
| # | Name | Date |
|---|---|---|
| 1 | 202417049179-STATEMENT OF UNDERTAKING (FORM 3) [27-06-2024(online)].pdf | 2024-06-27 |
| 3 | 202417049179-Sequence Listing in PDF [27-06-2024(online)].pdf | 2024-06-27 |
| 4 | 202417049179-REQUEST FOR EXAMINATION (FORM-18) [27-06-2024(online)].pdf | 2024-06-27 |
| 5 | 202417049179-RELEVANT DOCUMENTS [27-06-2024(online)].pdf | 2024-06-27 |
| 6 | 202417049179-POWER OF AUTHORITY [27-06-2024(online)].pdf | 2024-06-27 |
| 7 | 202417049179-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [27-06-2024(online)].pdf | 2024-06-27 |
| 8 | 202417049179-MARKED COPIES OF AMENDEMENTS [27-06-2024(online)].pdf | 2024-06-27 |
| 9 | 202417049179-FORM-26 [27-06-2024(online)].pdf | 2024-06-27 |
| 10 | 202417049179-FORM 18 [27-06-2024(online)].pdf | 2024-06-27 |
| 11 | 202417049179-FORM 13 [27-06-2024(online)].pdf | 2024-06-27 |
| 12 | 202417049179-FORM 1 [27-06-2024(online)].pdf | 2024-06-27 |
| 13 | 202417049179-DECLARATION OF INVENTORSHIP (FORM 5) [27-06-2024(online)].pdf | 2024-06-27 |
| 14 | 202417049179-COMPLETE SPECIFICATION [27-06-2024(online)].pdf | 2024-06-27 |
| 15 | 202417049179-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [27-06-2024(online)].pdf | 2024-06-27 |
| 16 | 202417049179-AMMENDED DOCUMENTS [27-06-2024(online)].pdf | 2024-06-27 |
| 17 | 202417049179-Proof of Right [27-12-2024(online)].pdf | 2024-12-27 |
| 18 | 202417049179-FORM 3 [27-12-2024(online)].pdf | 2024-12-27 |